|
Minimally Invasive High Intensity Ultrasound Treatment of Uterine Fibroids
|
5R44CA121740-03
|
$640,042
|
$640,042
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Molecular Pathoepidemiology of Endometrial Cancer Risk
|
5R01CA082838-13
|
$430,973
|
$430,973
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S1
|
$37,026
|
$741
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S2
|
$49,999
|
$1,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-25
|
$4,878,887
|
$97,578
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-01S1
|
$171,796
|
$8,590
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-02
|
$1,360,245
|
$68,012
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Revving-Up Exercise for Sustained Weight-Loss by Altering Neurological Reward & D
|
5R01CA175100-03
|
$511,711
|
$511,711
|
NOCK, NORA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
2U54CA143931-06
|
$1,808,129
|
$54,244
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-02
|
$1,171,980
|
$14,650
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-02
|
$319,472
|
$7,987
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-02
|
$411,893
|
$20,595
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
EORTC HEADQUARTERS
|
5U10CA011488-45
|
$250,025
|
$5,001
|
LACOMBE, DENIS
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI
|
3UM1CA173642-03S1
|
$113,842
|
$18,215
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-03
|
$2,539,856
|
$406,377
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Addressing Psychosocial Disparities in Rural Hispanic Cancer Survivors
|
5K01CA154938-05
|
$139,976
|
$34,994
|
CEBALLOS, RACHEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SWOG Statistics and Data Management Center
|
5U10CA180819-02
|
$6,686,248
|
$66,862
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Behavioral Economics and Improving Chemotherapy Decisions for Advanced Cancer
|
5K24CA181510-02
|
$174,725
|
$57,659
|
KEATING, NANCY
|
HARVARD MEDICAL SCHOOL
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-02
|
$280,000
|
$2,800
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
3U10CA180802-02S1
|
$100,000
|
$5,000
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
5U10CA180802-02
|
$639,550
|
$31,978
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$105,182
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
The Role of Bioactive Lipids in Inflammation and Cancer
|
5P01CA077839-14
|
$1,079,794
|
$356,332
|
DUBOIS, RAYMOND
|
MAYO CLINIC ARIZONA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$12,959
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-41
|
$5,755,389
|
$57,554
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome
|
5R21CA180997-02
|
$172,095
|
$43,024
|
JATOI, AMINAH
|
MAYO CLINIC ROCHESTER
|
|
Research Management and Support
|
RMS ES 2015
|
$348,215,937
|
$345,178
|
Unknown, Unknown
|
National Cancer Institute
|
|
Molecular characterization of endometrial cancer
|
ZIA BC 011315
|
$43,679
|
$43,679
|
Annunziata, Christina
|
CCR (NCI)
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$174,715
|
$8,736
|
Annunziata, Christina
|
CCR (NCI)
|
|
GOG Studies
|
ZIA CP010126 - 01068
|
$35,305
|
$28,244
|
Brinton, Louise
|
DCEG (NCI)
|
|
Columbia, Missouri serum bank participant extended follow-up
|
ZIA CP010126 - 01103
|
$23,305
|
$2,331
|
Brinton, Louise
|
DCEG (NCI)
|
|
Endometrial cancer epidemiologic study
|
ZIA CP010126 - 03050
|
$1,765
|
$1,765
|
Brinton, Louise
|
DCEG (NCI)
|
|
FIT - Bone mineral density and subsequent cancer risk
|
ZIA CP010128 - 01063
|
$26,569
|
$5,314
|
Brinton, Louise
|
DCEG (NCI)
|
|
Infertility follow-up study: 1965-88
|
ZIA CP010128 - 01082
|
$116,147
|
$17,422
|
Brinton, Louise
|
DCEG (NCI)
|
|
In vivo Imaging Analysis of Steroid/Nuclear Receptor Function
|
ZIA BC 010308
|
$533,476
|
$106,695
|
Hager, Gordon
|
CCR (NCI)
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168 - 00020
|
$1,856,582
|
$185,658
|
Hoover, Robert
|
DCEG (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$822,004
|
$82,200
|
Hou, Steven
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,773
|
$25,789
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,031,546
|
$51,577
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$773,659
|
$77,366
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
|
ZIA BC 005177
|
$418,113
|
$167,245
|
Poirier, Miriam
|
CCR (NCI)
|
|
Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs
|
ZIA BC 010770
|
$776,495
|
$232,948
|
Poirier, Miriam
|
CCR (NCI)
|
|
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
|
ZIA BC 010834
|
$359,188
|
$35,919
|
Ried, Thomas
|
CCR (NCI)
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182 - 01030
|
$62,605
|
$6,261
|
Schairer, Catherine
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,131,149
|
$56,557
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126 - 10538
|
$403,829
|
$201,915
|
Trabert, Britton
|
DCEG (NCI)
|
|
IVF in Israel
|
ZIA CP010128 - 10730
|
$71,289
|
$3,564
|
Trabert, Britton
|
DCEG (NCI)
|
|
Norwegian Studies of the Association of Pregnancy and Perinatal Characteristics w
|
ZIA CP010168 - 10041
|
$120,213
|
$12,021
|
Troisi, Rebecca
|
DCEG (NCI)
|
|
Identification of human tumor-associated antigens
|
ZIA BC 010972
|
$416,154
|
$41,615
|
Tsang, Kwong
|
CCR (NCI)
|
Total relevant funding to Uterine for this search: $12,987,815
|